ERAS-0015 Phase 1 data, valuation gap, Merck deal, funding, and key risks like patents. Click for more on ERAS stock.
KIT-targeting antibody biotech Jasper Therapeutics is being renewed via a merger with Nasdaq-listed Kira Pharmaceuticals—but ...
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only ...
The speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former FDA commissioner Marty Makary.
Pfizer and Amgen both grew revenue last quarter at nearly the same pace, but the engines driving that growth point toward two very different futures in oncology. One company is collecting cash from ...
Regulators on both sides of the Atlantic are pushing for the withdrawal of the rare disease treatment that accounted for just 1% of Amgen’s 2025 revenue. Nevertheless, Amgen continues to defend the ...
Amgen focuses on discovering and manufacturing medicines for serious diseases across several therapeutic areas. It sells its products globally, reaching customers in more than 50 countries including ...
Amgen is a global leader in drug manufacturing, focusing on large-scale treatments for chronic conditions. NovoCure specializes in proprietary wearable technology to treat various forms of cancer.
I'm Tazeen Ahmad. I'm one of the senior biotech analysts here at the bank. It's my pleasure to have our next presenting company, Amgen. Sitting up on stage, our several members from the Amgen team.
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of ...
Biotech firm Amgen will invest an additional US$300 million at its bioproduction facility in Juncos, Peurto Rico, building on the $650 million expansion that it announced last September. The firm has ...
Amgen is putting $300 million more into expanding its U.S. manufacturing, with the money going toward enlarging its biologics plant in Puerto Rico. The biotechnology company said Monday that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results